SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-138040
Filing Date
2016-08-09
Accepted
2016-08-08 20:42:54
Documents
51
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11641_110q.htm 10-Q 960801
2 EX-10.1 a16-11641_1ex10d1.htm EX-10.1 654843
3 EX-10.2 a16-11641_1ex10d2.htm EX-10.2 30321
4 EX-31.1 a16-11641_1ex31d1.htm EX-31.1 12928
5 EX-31.2 a16-11641_1ex31d2.htm EX-31.2 12913
6 EX-32 a16-11641_1ex32.htm EX-32 10717
13 GRAPHIC g116411ks17i001.jpg GRAPHIC 4685
14 GRAPHIC g116411ks17i002.jpg GRAPHIC 6784
  Complete submission text file 0001104659-16-138040.txt   3838548

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tbph-20160630.xml EX-101.INS 494835
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tbph-20160630.xsd EX-101.SCH 28617
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tbph-20160630_cal.xml EX-101.CAL 41297
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tbph-20160630_def.xml EX-101.DEF 84158
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tbph-20160630_lab.xml EX-101.LAB 252723
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tbph-20160630_pre.xml EX-101.PRE 177969
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 161815813
SIC: 2834 Pharmaceutical Preparations